These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12685887)

  • 1. Natural history of hyperlactataemia in human immunodeficiency virus-1-infected patients during highly active antiretroviral therapy.
    Huynh TK; Lüttichau HR; Roge BT; Gerstoft J
    Scand J Infect Dis; 2003; 35(1):62-6. PubMed ID: 12685887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG; Karstaedt AS
    Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic hyperlactataemia: predictive value, natural history and correlates.
    McComsey GA; Yau L
    Antivir Ther; 2004 Apr; 9(2):205-12. PubMed ID: 15134182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy.
    Alimenti A; Burdge DR; Ogilvie GS; Money DM; Forbes JC
    Pediatr Infect Dis J; 2003 Sep; 22(9):782-9. PubMed ID: 14506368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women.
    Currier JS
    Clin Infect Dis; 2007 Jul; 45(2):261-2. PubMed ID: 17578789
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment.
    Noguera A; Fortuny C; Sanchez E; Artuch R; Vilaseca MA; Muñoz-Almagro C; Pou J; Jiménez R
    Pediatr Infect Dis J; 2003 Sep; 22(9):778-82. PubMed ID: 14506367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlactataemia during antiretroviral therapy: incidences, clinical data and treatment.
    Gérard Y; Viget N; Yazdanpanah Y; Ajana F; de La Tribonnière X; Bocket L; Deuffic-Burban S; Dos Santos A; Ballester L; Mouton Y
    Therapie; 2003; 58(2):153-8. PubMed ID: 12942856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.
    Patel AK; Patel K; Patel J
    J Assoc Physicians India; 2004 Aug; 52():666-9. PubMed ID: 15847366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy.
    Gérard Y; Maulin L; Yazdanpanah Y; De La Tribonnière X; Amiel C; Maurage CA; Robin S; Sablonnière B; Dhennain C; Mouton Y
    AIDS; 2000 Dec; 14(17):2723-30. PubMed ID: 11125891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial).
    Feeney ER; Chazallon C; O'Brien N; Meiffrédy V; Goodall RL; Aboulker JP; Cooper DA; Yeni P; Mallon PW;
    HIV Med; 2011 Nov; 12(10):602-9. PubMed ID: 21599820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.
    Rajesh R; Vidyasagar S; Varma DM; Mohiuddin S; Noorunnisa
    Int J Risk Saf Med; 2011; 23(3):171-80. PubMed ID: 22020397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors.
    Moyle GJ; Datta D; Mandalia S; Morlese J; Asboe D; Gazzard BG
    AIDS; 2002 Jul; 16(10):1341-9. PubMed ID: 12131210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.
    Lichtenstein KA; Armon C; Baron A; Moorman AC; Wood KC; Holmberg SD;
    Clin Infect Dis; 2005 Jan; 40(1):148-57. PubMed ID: 15614705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the development of lipodystrophy in human immunodeficiency virus-infected patients.
    Collazos J; Rodriguez-Guardado A; Maradona JA; Mayo J; Asensi V; Ibarra S; Carton JA; Casado L
    Scand J Infect Dis; 2003; 35(5):339-40. PubMed ID: 12875524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy.
    Lactic Acidosis International Study Group
    AIDS; 2007 Nov; 21(18):2455-64. PubMed ID: 18025882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy.
    Ando M; Yanagisawa N; Ajisawa A; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2011 Oct; 26(10):3224-9. PubMed ID: 21372250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.